An enzyme from the bacterium Escherichia coli is the 'special observed' in colon cancer

One of the factors involved in the development of this type of cancer is the E.coli pks+ enzyme, which is present in Escherichia coli bacteria. This is the result of a joint study by Milano-Bicocca, Human Technopole and the London Cancer Research Institute, just published in Nature Communications, which opens up new prospects for prevention and treatment.

Global pandemics and crises: the critical role of behavioural science in policy making

The results of an international study published in Nature show how the alliance between scientists and decision-makers can be crucial in critical global contexts. Among the 80 researchers from 30 countries involved was Valerio Capraro, Professor of the Psychology of Moral Decisions at the University of Milan-Bicocca.

A possible challenge: preventing cognitive decline

New IRCCS San Gerardo - University of Milano-Bicocca outpatient clinic for subjective cognitive decline

Positive results of brain stem cell transplantation in patients with secondary progressive multiple sclerosis

The prestigious journal Cell Stem Cell publishes a study of a phase 1 clinical trial, finally paving the way for phase 2 clinical trials, and dedicates its cover to it.

Milano-Bicocca receives €2.4 million ERC Advanced Grant for cosmology research

European funding won by Professor Federico Nati of the Department of Physics will be used to set up a system of artificial airborne sources on drones and balloons to calibrate the telescopes of the Simons Observatory in the Atacama Desert in Chile, and to make frontier measurements for fundamental discoveries about the dawn of the universe.

Closer to the people: Milano-Bicocca opens the new academic year with a focus on the Fourth Mission

The University of Milano-Bicocca, which has just celebrated its first 25 years, is increasingly looking at its social impact on the region and society.

Milano-Bicocca leads European project to develop advanced radiation detectors using nanotechnology

Called Unicorn, it has received €3 million from the EIC Pathfinder Open 2022 call for proposals and will involve six other partners, including Cern, the Italian Institute of Technology and the Academy of Sciences in Prague.